Marsh & McLennan, US5717481023

Marsh & McLennan stock slips to EUR 187.78, down 1.61%

Published on 11/18/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Morgan Stanley raised its price target to USD 215 from USD 190 while keeping an Equal Weight rating. On Xetra, the stock closed at EUR 190.85 on Monday, November 16, 2026.

Key points for investors

  • Morgan Stanley raised its price target to USD 215 from USD 190 and maintained an Equal Weight rating on November 16.
  • The bank expects a softer insurance market cycle into 2027 despite broadly solid third-quarter earnings across the sector.
  • Marsh & McLennan provides risk, strategy, people and investment services to corporate and institutional clients.
Marsh & McLennan, US5717481023, Illustration mit AI erstellt.

Marsh & McLennan stock slipped before the European session. The move came as investors assessed a new analyst target and a more cautious outlook for the insurance cycle.

Marsh & McLennan stock traded at EUR 187.78 on Lang & Schwarz at 07:53 CET on Wednesday, November 18, 2026, 1.61 percent below the Xetra close of Tuesday, November 17, 2026, at EUR 190.85.

On November 16, Morgan Stanley raised its price target for Marsh & McLennan to USD 215 from USD 190 and kept an Equal Weight rating, according to Markets Insider. The bank cited broadly solid third-quarter earnings across North American property and casualty insurers but said the trend into 2027 appeared weaker and that the market cycle could soften further.

The company serves corporate and institutional clients through risk, strategy, people and investment services. The analyst view leaves the shares with a neutral rating while pointing to a more cautious cycle outlook rather than a company-specific earnings revision.

US equities will set the broader tone for the session through the S&P 500.

More news and analyses on Marsh & McLennan stock

Disclaimer...
en | US5717481023 | MARSH & MCLENNAN | boerse | 70529808 | bgmi